Axios

It's little surprise that America is rapidly getting older — but now that we're at the brink of that demographic shift's major consequences, we're still completely unprepared.

Why it matters: It's not just that seniors are an increasing share of the population, which is a huge challenge in itself. The seniors of the future may also require care for longer, and aging inequalities are becoming more stark.

A startup tampon brand is aiming to disrupt the world of menstrual products with a patented spiral design for fewer leaks.

Why it matters: It's "the first engineering redesign of the tampon in 80 years" according to Sequel, which aims to change the game for women athletes.

Thinking up a name for a little one on the way? Consider "Theo," "Atlas" or "Nova."

The big picture: Those three have risen the most in popularity since 2013, according to new Social Security Administration data.

Federal health regulators on Wednesday suspended funding to EcoHealth Alliance, less than a month after a congressional committee grilled the nonprofit's president over its ties with the Wuhan Institute of Virology.

Why it matters: It marked an abrupt turn for the organization, whose funding of studies on bat coronaviruses in China put it at the center of the debate over the pandemic's origins.

Patients prescribed highly effective anti-obesity medications are growing anxious about the increasing difficulty of obtaining them amid long-running shortages driven by blockbuster demand for the drugs.

Why it matters: Their ongoing struggle to locate reliable supplies of drugs like Novo Nordisk's Wegovy is fueling fears among patients that even a brief disruption to their dosing schedule could set back their progress, doctors who prescribe the drugs told Axios.